The Endocrinology and Metabolism Research Training Program (T32) at Duke University Medical Center consists of an interactive matrix of clinical and basic science divisions, departments and centers. The mission of this program is to develop the next generation of biomedical researchers in Endocrinology and Metabolism. The trainees will be either board- eligible or certified physicians who have trained in Internal Medicine or Pediatrics, or non- physician science graduates who wish to pursue careers in endocrine/metabolic research. The Endocrinology T32 has a long history of training successful investigators in diabetes, metabolic bone disease, and other areas of endocrine/metabolic research. A substantial majority (83% over the past 10 years who are not still in training) are in academic positions at major medical centers across the US and abroad. Most are in positions with substantial research components, supported by federal, foundation, or industry grants, and the remainder have significant teaching responsibilities. They have almost 300 publications since they began their Endocrinology research training. The program includes training opportunities in clinical, translational, and basic research. Seven different research training modules have been designed to allow the trainee exposure to some of the most important areas of endocrine/metabolic research today, and afford the opportunity for training with outstanding scientists and mentors. These modules range from those solely devoted to basic science (Nuclear Receptor Signaling and Pharmacology; G Protein-Coupled Receptors) to those with basic and clinical/translational arms (Diabetes, Obesity and Nutrient Metabolism; Metabolic Components of Cardiovascular Disease; Bone and Mineral Metabolism; Pediatric Endocrinology; Women's Health). Trainees are jointly mentored by basic and clinical research scientists to promote broader understanding of research concepts, and also attend didactic teaching programs designed to provide the tools necessary for success in a research career. Training is aimed at promoting the understanding, design and use of biochemical, physiological and molecular biological approaches to endocrine and metabolic problems, as well as proficiency in laboratory and clinical investigation techniques. Individuals who complete the program will be capable of independent investigation and able to translate research accomplishments into significant advances with clinical relevance.

Public Health Relevance

Diseases such as diabetes, osteoporosis, obesity, and high cholesterol are critical, and growing, public health problems in the United States as well as the rest of the world. Diabetes and its complications alone is responsible for every fifth health care dollar spent in the US, by some estimates. In our state of North Carolina, 29.4% of the population is obese, and 9.6% have diabetes. Furthermore, the impact on minority populations is disproportionately high. There is a nationwide shortage of endocrinologists, and endocrine researchers are in particularly short supply. More must be trained. The Duke University Medical Center T32 Research Training Program in Endocrinology and Metabolism has a mission to recruit and train outstanding physicians and other medical scientists for careers in endocrine/metabolic research in an outstanding multifaceted environment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007012-38S1
Application #
9392670
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK-B)
Program Officer
Castle, Arthur
Project Start
1975-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
38
Fiscal Year
2017
Total Cost
$4,925
Indirect Cost
$365
Name
Duke University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Rhea, Elizabeth M; Salameh, Therese S; Gray, Sarah et al. (2018) Ghrelin transport across the blood-brain barrier can occur independently of the growth hormone secretagogue receptor. Mol Metab 18:88-96
Page, Laura C; Gastaldelli, Amalia; Gray, Sarah M et al. (2018) Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans. Diabetes 67:1976-1985
Douros, Jonathan D; Lewis, Alfor G; Smith, Eric P et al. (2018) Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a ?-Cell Glucagon-Like Peptide 1 Receptor. Diabetes 67:1504-1511
Wagner, Gregory R; Bhatt, Dhaval P; O'Connell, Thomas M et al. (2017) A Class of Reactive Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation. Cell Metab 25:823-837.e8
Anderson, Kristin A; Huynh, Frank K; Fisher-Wellman, Kelsey et al. (2017) SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. Cell Metab 25:838-855.e15
Wagner, Gregory R; Hirschey, Matthew D (2017) A Prob(e)able Route to Lysine Acylation. Cell Chem Biol 24:126-128
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela A et al. (2016) Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Endocrine 52:579-86
McVay, Megan A; Voils, Corrine I; Geiselman, Paula J et al. (2016) Food preferences and weight change during low-fat and low-carbohydrate diets. Appetite 103:336-343
Ruel, Ewa; Thomas, Samantha; Dinan, Michaela et al. (2015) Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab 100:1529-36
Okorodudu, Daniel E; Bosworth, Hayden B; Corsino, Leonor (2015) Innovative interventions to promote behavioral change in overweight or obese individuals: A review of the literature. Ann Med 47:179-85

Showing the most recent 10 out of 57 publications